Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Saem Lee
Boston VA Research Institute, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Little Rock Va Medical Center
Little Rock, Arkansas, United States
- West Los Angeles Va Medical Center
Los Angeles, California, United States
- San Francisco Va Medical Center
San Francisco, California, United States
- Eastern Colorado Health Care System
Denver, Colorado, United States
- West Haven Va Medical Center
West Haven, Connecticut, United States
- Tampa Va Medical Center
Tampa, Florida, United States
- Atlanta Va Medical Center
Atlanta, Georgia, United States
- Va Boston Healthcare System
Jamaica Plain, Massachusetts, United States
- Kansas City Va Medical Center
Kansas City, Missouri, United States
- Pittsburgh Va Medical Center
Pittsburgh, Pennsylvania, United States
- Michael E. Debakey Va Medical Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Mar 2015
- Completion
- 31 Mar 2015
- Last update posted
- 9 Sept 2020
- Registered enrollment
- 50
- Registry id
- NCT01090921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.